Key Highlights
- Brian J. Blaser appointed as President and CEO of QuidelOrtho, effective May 6, 2024.
- Blaser’s vast experience includes over 25 years in senior leadership roles in the in-vitro diagnostics industry.
- Strategic Vision: Blaser aims to enhance QuidelOrtho’s innovation and growth, improving profitability and customer service.
Source: Business Wire
Notable Quotes
- “We are excited to welcome Brian as our new president, CEO and director,” – Kenneth F. Buechler, Ph.D., Chairman of the Board at QuidelOrtho
- “I am honored and excited to join QuidelOrtho as president and CEO during this pivotal point in the Company’s journey.” – Brian J. Blaser, President and CEO at QuidelOrtho
SoHC's Take
Brian J. Blaser’s appointment as President and CEO of QuidelOrtho marks a significant step in the company’s journey towards leading the in-vitro diagnostic sector with innovative solutions. His previous roles at Abbott Laboratories and his extensive experience in operational strategy and diagnostic management signal a promising future for QuidelOrtho. Under his leadership, the company is poised to enhance its service delivery and operational efficiency, ensuring improved healthcare outcomes globally. This strategic move also reaffirms QuidelOrtho’s commitment to excellence and its focus on leveraging industry expertise to foster growth and profitability in a competitive market.
